Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
Other TitlesHepatocellular carcinoma in Iceland
CitationLæknablaðið 2001, 87(6):527-31
AbstractIntroduction: The incidence of hepatocellular carcinoma (HCC) varies throughout the world, being relatively low in Northern Europe (less than five per 100,000 population) where the majority of the patients have cirrhosis. In Iceland the prevalence of viral hepatitis and cirrhosis, the main risk factors for HCC, is lower than reported in many other countries. The aim of our study was to investigate the incidence and etiology of HCC in Iceland. Material and methods: All patients diagnosed with HCC in Iceland in 1984-1998 were included in the study. Histologic diagnosis was required for inclusion. Patients were identified from the Icelandic Cancer Registry and by reviewing autopsy and histopathology reports. Further information was obtained from medical records. Results: A total of 71 cases of HCC were identified, 51 males and 20 females. The mean age for males was 69.3 years (18-95) and 73 years (52-89) for females. The age-standardized annual incidence rate of HCC was 1.08/100,000 (males 2.10, females 0.67). The incidence did not increase significantly during the study period. Alcohol abuse (15.5%) and hemochromatosis (11%) were the most common risk factors. Twenty-three (32%) had cirrhosis but 39 (55%) had no known risk factors. Of 55 cases where non-neoplastic tissue was available for examination, 27 had liver disease. Conclusions: 1) The incidence of HCC in Iceland is lower than reported in other countries. 2) Alcohol abuse and hemochromatosis are the most common risk factors. 3) The ratio of patients with cirrhosis is low.
DescriptionNeðst á síðunni er hægt að nálgast greinina í heild sinni með því að smella á hlekkinn View/Open
- Hepatocellular carcinoma and hepatic cirrhosis in Mexico: a 25 year necroscopy review.
- Authors: Cortes-Espinosa T, Mondragón-Sánchez R, Hurtado-Andrade H, Sánchez-Cisneros R
- Issue date: 1997 Sep-Oct
- A nationwide population-based prospective study of cirrhosis in Iceland.
- Authors: Olafsson S, Rögnvaldsson S, Bergmann OM, Jonasson JG, Benitez Hernandez U, Björnsson ES
- Issue date: 2021 Jun
- Racial differences in the progression to cirrhosis and hepatocellular carcinoma in HCV-infected veterans.
- Authors: El-Serag HB, Kramer J, Duan Z, Kanwal F
- Issue date: 2014 Sep
- Hepatocellular carcinoma incidence in noncirrhotic patients with chronic hepatitis B and patients with cirrhosis of all etiologies.
- Authors: Do AL, Wong CR, Nguyen LH, Nguyen VG, Trinh H, Nguyen MH
- Issue date: 2014 Aug
- Epidemiology, clinical-treatment patterns and outcome in 256 hepatocellular carcinoma cases.
- Authors: Fenoglio L, Serraino C, Castagna E, Cardellicchio A, Pomero F, Grosso M, Senore C
- Issue date: 2013 Jun 7